As Biden sig­nals in­ter­est in link­ing drug prices with R&D costs, new study finds costs per NME are in­creas­ing

Eroom’s law (es­sen­tial­ly the op­po­site of Moore’s law) holds that the de­vel­op­ment of new drugs has be­come slow­er and more ex­pen­sive over time. And a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.